Outcomes of parenteral nutrition in patients with advanced cancer and malignant bowel obstruction.

ABSTRACT:

Background

Malignant bowel obstruction (MBO) affects 3-15% of all cancer patients. In patients with advanced cancer and inoperable MBO, the average survival varies between four to nine weeks. Parenteral nutrition (PN) may improve survival in specific patient populations with malignant bowel obstruction.

Aims

This retrospective, single-center cohort study aimed to review individual patient outcomes on PN in the setting of advanced cancer with a diagnosis of MBO and identify clinical and laboratory markers predictive of short- and long-term survival to further highlight patients that would benefit from PN in the setting of an inoperable MBO.

Results

In a retrospective analysis of 68 patients receiving PN for inoperable MBO, the median survival was 142 (IQR: 63.3-239.5)

SUBMITTER: Velasquez DA 

PROVIDER: S-EPMC10680932 | biostudies-literature | 2023 Nov

REPOSITORIES: biostudies-literature